Skip to main content

Table 1 Quantitative analysis of serum NE and MMP-2 in COPD patients vs the controls

From: Elevated serum matrix metalloprotease (MMP-2) as a candidate biomarker for stable COPD

  Neutrophil elastase (μg/ml) Matrix metalloprotease-2 (μg/ml)
Controls 0.047 ± 0.014 0.05 ± 0.0083
COPD patients 0.21 ± 0.018 0.71 ± 0.0647